KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to -$235000.0.

  • Aquestive Therapeutics' Cash from Investing Activities fell 19375.0% to -$235000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$492000.0, marking a year-over-year decrease of 20750.0%. This contributed to the annual value of -$159000.0 for FY2024, which is 8402.01% up from last year.
  • Per Aquestive Therapeutics' latest filing, its Cash from Investing Activities stood at -$235000.0 for Q3 2025, which was down 19375.0% from -$107000.0 recorded in Q2 2025.
  • In the past 5 years, Aquestive Therapeutics' Cash from Investing Activities registered a high of -$2000.0 during Q1 2023, and its lowest value of -$1.7 million during Q3 2022.
  • Its 5-year average for Cash from Investing Activities is -$266736.8, with a median of -$104000.0 in 2022.
  • As far as peak fluctuations go, Aquestive Therapeutics' Cash from Investing Activities plummeted by 196867.47% in 2022, and later surged by 9807.69% in 2023.
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Cash from Investing Activities stood at -$533000.0 in 2021, then skyrocketed by 95.12% to -$26000.0 in 2022, then soared by 38.46% to -$16000.0 in 2023, then rose by 6.25% to -$15000.0 in 2024, then tumbled by 1466.67% to -$235000.0 in 2025.
  • Its Cash from Investing Activities stands at -$235000.0 for Q3 2025, versus -$107000.0 for Q2 2025 and -$135000.0 for Q1 2025.